CN114045263B - Method for precisely separating rat KISS1 neurons - Google Patents
Method for precisely separating rat KISS1 neurons Download PDFInfo
- Publication number
- CN114045263B CN114045263B CN202111136595.XA CN202111136595A CN114045263B CN 114045263 B CN114045263 B CN 114045263B CN 202111136595 A CN202111136595 A CN 202111136595A CN 114045263 B CN114045263 B CN 114045263B
- Authority
- CN
- China
- Prior art keywords
- kiss1
- cells
- neurons
- rat
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002569 neuron Anatomy 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title claims abstract description 35
- 101100288071 Rattus norvegicus Kiss1 gene Proteins 0.000 title claims abstract description 15
- 210000004027 cell Anatomy 0.000 claims abstract description 121
- 230000014509 gene expression Effects 0.000 claims abstract description 53
- 101001091223 Homo sapiens Metastasis-suppressor KiSS-1 Proteins 0.000 claims abstract description 49
- RITKWYDZSSQNJI-INXYWQKQSA-N (2s)-n-[(2s)-1-[[(2s)-4-amino-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-[[(2s)-1-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino] Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 RITKWYDZSSQNJI-INXYWQKQSA-N 0.000 claims abstract description 47
- 229910020769 KISS1 Inorganic materials 0.000 claims abstract description 47
- 102100034841 Metastasis-suppressor KiSS-1 Human genes 0.000 claims abstract description 47
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 46
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 29
- 210000003016 hypothalamus Anatomy 0.000 claims abstract description 17
- 210000000170 cell membrane Anatomy 0.000 claims abstract description 12
- 238000000684 flow cytometry Methods 0.000 claims abstract description 5
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 claims description 25
- 108700012813 7-aminoactinomycin D Proteins 0.000 claims description 25
- 101150088805 Slc18a3 gene Proteins 0.000 claims description 21
- 210000004556 brain Anatomy 0.000 claims description 11
- 239000008363 phosphate buffer Substances 0.000 claims description 11
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000012163 sequencing technique Methods 0.000 claims description 10
- 210000004498 neuroglial cell Anatomy 0.000 claims description 9
- 239000012266 salt solution Substances 0.000 claims description 9
- 239000006285 cell suspension Substances 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- 230000009467 reduction Effects 0.000 claims description 7
- 238000011534 incubation Methods 0.000 claims description 6
- 239000000523 sample Substances 0.000 claims description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 4
- 239000002299 complementary DNA Substances 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 230000001464 adherent effect Effects 0.000 claims description 2
- 239000012894 fetal calf serum Substances 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 241000700159 Rattus Species 0.000 abstract description 44
- 230000009261 transgenic effect Effects 0.000 abstract description 5
- 238000000605 extraction Methods 0.000 abstract description 4
- 108091005461 Nucleic proteins Proteins 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 abstract description 2
- 108020004707 nucleic acids Proteins 0.000 abstract description 2
- 102000039446 nucleic acids Human genes 0.000 abstract description 2
- 150000007523 nucleic acids Chemical class 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 230000002267 hypothalamic effect Effects 0.000 description 14
- 108010012048 Kisspeptins Proteins 0.000 description 7
- 102000013599 Kisspeptins Human genes 0.000 description 7
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000005090 green fluorescent protein Substances 0.000 description 6
- KAHDONZOCXSKII-NJVVDGNHSA-N kisspeptin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C1=CN=CN1 KAHDONZOCXSKII-NJVVDGNHSA-N 0.000 description 6
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 102000005936 beta-Galactosidase Human genes 0.000 description 5
- 108010005774 beta-Galactosidase Proteins 0.000 description 5
- 101150075823 KISS1 gene Proteins 0.000 description 4
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 4
- 241000700157 Rattus norvegicus Species 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 3
- 210000005013 brain tissue Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 108010078144 glutaminyl-glycine Proteins 0.000 description 3
- 238000002826 magnetic-activated cell sorting Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- 101100316741 Danio rerio slc18a3b gene Proteins 0.000 description 2
- 206010058314 Dysplasia Diseases 0.000 description 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 2
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 2
- 102100034845 KiSS-1 receptor Human genes 0.000 description 2
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 2
- IDKGBVZGNTYYCC-QXEWZRGKSA-N Val-Asn-Pro Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(O)=O IDKGBVZGNTYYCC-QXEWZRGKSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 210000003295 arcuate nucleus Anatomy 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 229940028334 follicle stimulating hormone Drugs 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 101150108262 gnrh1 gene Proteins 0.000 description 2
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 2
- 229940035638 gonadotropin-releasing hormone Drugs 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000004185 hypothalamic-pituitary-gonadal axis Effects 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 238000007901 in situ hybridization Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000008141 pubertal development Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 108010020532 tyrosyl-proline Proteins 0.000 description 2
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 1
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- ODWSTKXGQGYHSH-FXQIFTODSA-N Ala-Arg-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O ODWSTKXGQGYHSH-FXQIFTODSA-N 0.000 description 1
- NXSFUECZFORGOG-CIUDSAMLSA-N Ala-Asn-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXSFUECZFORGOG-CIUDSAMLSA-N 0.000 description 1
- BTBUEVAGZCKULD-XPUUQOCRSA-N Ala-Gly-His Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BTBUEVAGZCKULD-XPUUQOCRSA-N 0.000 description 1
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 1
- TZDNWXDLYFIFPT-BJDJZHNGSA-N Ala-Ile-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O TZDNWXDLYFIFPT-BJDJZHNGSA-N 0.000 description 1
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 1
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- FUKFQILQFQKHLE-DCAQKATOSA-N Ala-Lys-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O FUKFQILQFQKHLE-DCAQKATOSA-N 0.000 description 1
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 1
- MAZZQZWCCYJQGZ-GUBZILKMSA-N Ala-Pro-Arg Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MAZZQZWCCYJQGZ-GUBZILKMSA-N 0.000 description 1
- ADSGHMXEAZJJNF-DCAQKATOSA-N Ala-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N ADSGHMXEAZJJNF-DCAQKATOSA-N 0.000 description 1
- OLVCTPPSXNRGKV-GUBZILKMSA-N Ala-Pro-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OLVCTPPSXNRGKV-GUBZILKMSA-N 0.000 description 1
- YHBDGLZYNIARKJ-GUBZILKMSA-N Ala-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N YHBDGLZYNIARKJ-GUBZILKMSA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 1
- AOAKQKVICDWCLB-UWJYBYFXSA-N Ala-Tyr-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N AOAKQKVICDWCLB-UWJYBYFXSA-N 0.000 description 1
- VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 1
- DFCIPNHFKOQAME-FXQIFTODSA-N Arg-Ala-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DFCIPNHFKOQAME-FXQIFTODSA-N 0.000 description 1
- NABSCJGZKWSNHX-RCWTZXSCSA-N Arg-Arg-Thr Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NABSCJGZKWSNHX-RCWTZXSCSA-N 0.000 description 1
- GIVWETPOBCRTND-DCAQKATOSA-N Arg-Gln-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GIVWETPOBCRTND-DCAQKATOSA-N 0.000 description 1
- LMPKCSXZJSXBBL-NHCYSSNCSA-N Arg-Gln-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O LMPKCSXZJSXBBL-NHCYSSNCSA-N 0.000 description 1
- OGUPCHKBOKJFMA-SRVKXCTJSA-N Arg-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N OGUPCHKBOKJFMA-SRVKXCTJSA-N 0.000 description 1
- XUUXCWCKKCZEAW-YFKPBYRVSA-N Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N XUUXCWCKKCZEAW-YFKPBYRVSA-N 0.000 description 1
- CYXCAHZVPFREJD-LURJTMIESA-N Arg-Gly-Gly Chemical compound NC(=N)NCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O CYXCAHZVPFREJD-LURJTMIESA-N 0.000 description 1
- LVMUGODRNHFGRA-AVGNSLFASA-N Arg-Leu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O LVMUGODRNHFGRA-AVGNSLFASA-N 0.000 description 1
- JCROZIFVIYMXHM-GUBZILKMSA-N Arg-Met-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCN=C(N)N JCROZIFVIYMXHM-GUBZILKMSA-N 0.000 description 1
- IJYZHIOOBGIINM-WDSKDSINSA-N Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N IJYZHIOOBGIINM-WDSKDSINSA-N 0.000 description 1
- JPAWCMXVNZPJLO-IHRRRGAJSA-N Arg-Ser-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JPAWCMXVNZPJLO-IHRRRGAJSA-N 0.000 description 1
- NVPHRWNWTKYIST-BPNCWPANSA-N Arg-Tyr-Ala Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=C(O)C=C1 NVPHRWNWTKYIST-BPNCWPANSA-N 0.000 description 1
- NTXNUXPCNRDMAF-WFBYXXMGSA-N Asn-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(N)=O)C)C(O)=O)=CNC2=C1 NTXNUXPCNRDMAF-WFBYXXMGSA-N 0.000 description 1
- VLDRQOHCMKCXLY-SRVKXCTJSA-N Asn-Ser-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O VLDRQOHCMKCXLY-SRVKXCTJSA-N 0.000 description 1
- LRCIOEVFVGXZKB-BZSNNMDCSA-N Asn-Tyr-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LRCIOEVFVGXZKB-BZSNNMDCSA-N 0.000 description 1
- VZNOVQKGJQJOCS-SRVKXCTJSA-N Asp-Asp-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VZNOVQKGJQJOCS-SRVKXCTJSA-N 0.000 description 1
- RXBGWGRSWXOBGK-KKUMJFAQSA-N Asp-Lys-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RXBGWGRSWXOBGK-KKUMJFAQSA-N 0.000 description 1
- IOXWDLNHXZOXQP-FXQIFTODSA-N Asp-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N IOXWDLNHXZOXQP-FXQIFTODSA-N 0.000 description 1
- GCACQYDBDHRVGE-LKXGYXEUSA-N Asp-Thr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC(O)=O GCACQYDBDHRVGE-LKXGYXEUSA-N 0.000 description 1
- LBOLGUYQEPZSKM-YUMQZZPRSA-N Cys-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N LBOLGUYQEPZSKM-YUMQZZPRSA-N 0.000 description 1
- HEPLXMBVMCXTBP-QWRGUYRKSA-N Cys-Phe-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O HEPLXMBVMCXTBP-QWRGUYRKSA-N 0.000 description 1
- ALTQTAKGRFLRLR-GUBZILKMSA-N Cys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N ALTQTAKGRFLRLR-GUBZILKMSA-N 0.000 description 1
- XOKGKOQWADCLFQ-GARJFASQSA-N Gln-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)N)N)C(=O)O XOKGKOQWADCLFQ-GARJFASQSA-N 0.000 description 1
- RBWKVOSARCFSQQ-FXQIFTODSA-N Gln-Gln-Ser Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O RBWKVOSARCFSQQ-FXQIFTODSA-N 0.000 description 1
- XFAUJGNLHIGXET-AVGNSLFASA-N Gln-Leu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XFAUJGNLHIGXET-AVGNSLFASA-N 0.000 description 1
- IIMZHVKZBGSEKZ-SZMVWBNQSA-N Gln-Trp-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(O)=O IIMZHVKZBGSEKZ-SZMVWBNQSA-N 0.000 description 1
- DIXKFOPPGWKZLY-CIUDSAMLSA-N Glu-Arg-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O DIXKFOPPGWKZLY-CIUDSAMLSA-N 0.000 description 1
- LXAUHIRMWXQRKI-XHNCKOQMSA-N Glu-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O LXAUHIRMWXQRKI-XHNCKOQMSA-N 0.000 description 1
- PVBBEKPHARMPHX-DCAQKATOSA-N Glu-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O PVBBEKPHARMPHX-DCAQKATOSA-N 0.000 description 1
- GJBUAAAIZSRCDC-GVXVVHGQSA-N Glu-Leu-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O GJBUAAAIZSRCDC-GVXVVHGQSA-N 0.000 description 1
- PMSMKNYRZCKVMC-DRZSPHRISA-N Glu-Phe-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)O)N PMSMKNYRZCKVMC-DRZSPHRISA-N 0.000 description 1
- AAJHGGDRKHYSDH-GUBZILKMSA-N Glu-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O AAJHGGDRKHYSDH-GUBZILKMSA-N 0.000 description 1
- SYWCGQOIIARSIX-SRVKXCTJSA-N Glu-Pro-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O SYWCGQOIIARSIX-SRVKXCTJSA-N 0.000 description 1
- QOXDAWODGSIDDI-GUBZILKMSA-N Glu-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N QOXDAWODGSIDDI-GUBZILKMSA-N 0.000 description 1
- BPCLDCNZBUYGOD-BPUTZDHNSA-N Glu-Trp-Glu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 BPCLDCNZBUYGOD-BPUTZDHNSA-N 0.000 description 1
- YQPFCZVKMUVZIN-AUTRQRHGSA-N Glu-Val-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O YQPFCZVKMUVZIN-AUTRQRHGSA-N 0.000 description 1
- XXGQRGQPGFYECI-WDSKDSINSA-N Gly-Cys-Glu Chemical compound NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCC(O)=O XXGQRGQPGFYECI-WDSKDSINSA-N 0.000 description 1
- GDOZQTNZPCUARW-YFKPBYRVSA-N Gly-Gly-Glu Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O GDOZQTNZPCUARW-YFKPBYRVSA-N 0.000 description 1
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 1
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 1
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 1
- AFWYPMDMDYCKMD-KBPBESRZSA-N Gly-Leu-Tyr Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 AFWYPMDMDYCKMD-KBPBESRZSA-N 0.000 description 1
- LOEANKRDMMVOGZ-YUMQZZPRSA-N Gly-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O LOEANKRDMMVOGZ-YUMQZZPRSA-N 0.000 description 1
- JYPCXBJRLBHWME-IUCAKERBSA-N Gly-Pro-Arg Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JYPCXBJRLBHWME-IUCAKERBSA-N 0.000 description 1
- HJARVELKOSZUEW-YUMQZZPRSA-N Gly-Pro-Gln Chemical compound [H]NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O HJARVELKOSZUEW-YUMQZZPRSA-N 0.000 description 1
- ZLCLYFGMKFCDCN-XPUUQOCRSA-N Gly-Ser-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(O)=O ZLCLYFGMKFCDCN-XPUUQOCRSA-N 0.000 description 1
- MYXNLWDWWOTERK-BHNWBGBOSA-N Gly-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN)O MYXNLWDWWOTERK-BHNWBGBOSA-N 0.000 description 1
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 108050002220 Green fluorescent protein, GFP Proteins 0.000 description 1
- 101001091205 Homo sapiens KiSS-1 receptor Proteins 0.000 description 1
- VSZALHITQINTGC-GHCJXIJMSA-N Ile-Ala-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VSZALHITQINTGC-GHCJXIJMSA-N 0.000 description 1
- VAXBXNPRXPHGHG-BJDJZHNGSA-N Ile-Ala-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)N VAXBXNPRXPHGHG-BJDJZHNGSA-N 0.000 description 1
- NYEYYMLUABXDMC-NHCYSSNCSA-N Ile-Gly-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)N NYEYYMLUABXDMC-NHCYSSNCSA-N 0.000 description 1
- AREBLHSMLMRICD-PYJNHQTQSA-N Ile-His-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N AREBLHSMLMRICD-PYJNHQTQSA-N 0.000 description 1
- PWUMCBLVWPCKNO-MGHWNKPDSA-N Ile-Leu-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PWUMCBLVWPCKNO-MGHWNKPDSA-N 0.000 description 1
- WLRJHVNFGAOYPS-HJPIBITLSA-N Ile-Ser-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N WLRJHVNFGAOYPS-HJPIBITLSA-N 0.000 description 1
- JCGMFFQQHJQASB-PYJNHQTQSA-N Ile-Val-His Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O JCGMFFQQHJQASB-PYJNHQTQSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 108010076800 Kisspeptin-1 Receptors Proteins 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- -1 LH) Proteins 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- CZCSUZMIRKFFFA-CIUDSAMLSA-N Leu-Ala-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O CZCSUZMIRKFFFA-CIUDSAMLSA-N 0.000 description 1
- XIRYQRLFHWWWTC-QEJZJMRPSA-N Leu-Ala-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XIRYQRLFHWWWTC-QEJZJMRPSA-N 0.000 description 1
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 1
- OGUUKPXUTHOIAV-SDDRHHMPSA-N Leu-Glu-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGUUKPXUTHOIAV-SDDRHHMPSA-N 0.000 description 1
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 1
- OMHLATXVNQSALM-FQUUOJAGSA-N Leu-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(C)C)N OMHLATXVNQSALM-FQUUOJAGSA-N 0.000 description 1
- DDVHDMSBLRAKNV-IHRRRGAJSA-N Leu-Met-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O DDVHDMSBLRAKNV-IHRRRGAJSA-N 0.000 description 1
- JDBQSGMJBMPNFT-AVGNSLFASA-N Leu-Pro-Val Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O JDBQSGMJBMPNFT-AVGNSLFASA-N 0.000 description 1
- JIHDFWWRYHSAQB-GUBZILKMSA-N Leu-Ser-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JIHDFWWRYHSAQB-GUBZILKMSA-N 0.000 description 1
- RGUXWMDNCPMQFB-YUMQZZPRSA-N Leu-Ser-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RGUXWMDNCPMQFB-YUMQZZPRSA-N 0.000 description 1
- RIHIGSWBLHSGLV-CQDKDKBSSA-N Leu-Tyr-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O RIHIGSWBLHSGLV-CQDKDKBSSA-N 0.000 description 1
- MVJRBCJCRYGCKV-GVXVVHGQSA-N Leu-Val-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MVJRBCJCRYGCKV-GVXVVHGQSA-N 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- RFQATBGBLDAKGI-VHSXEESVSA-N Lys-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCCCN)N)C(=O)O RFQATBGBLDAKGI-VHSXEESVSA-N 0.000 description 1
- HQXSFFSLXFHWOX-IXOXFDKPSA-N Lys-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCCN)N)O HQXSFFSLXFHWOX-IXOXFDKPSA-N 0.000 description 1
- OGAZPKJHHZPYFK-GARJFASQSA-N Met-Glu-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGAZPKJHHZPYFK-GARJFASQSA-N 0.000 description 1
- MYAPQOBHGWJZOM-UWVGGRQHSA-N Met-Gly-Leu Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C MYAPQOBHGWJZOM-UWVGGRQHSA-N 0.000 description 1
- UZVKFARGHHMQGX-IUCAKERBSA-N Met-Gly-Met Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCSC UZVKFARGHHMQGX-IUCAKERBSA-N 0.000 description 1
- FZUNSVYYPYJYAP-NAKRPEOUSA-N Met-Ile-Ala Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O FZUNSVYYPYJYAP-NAKRPEOUSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- WYBVBIHNJWOLCJ-UHFFFAOYSA-N N-L-arginyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCCN=C(N)N WYBVBIHNJWOLCJ-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 1
- GYEPCBNTTRORKW-PCBIJLKTSA-N Phe-Ile-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O GYEPCBNTTRORKW-PCBIJLKTSA-N 0.000 description 1
- ALJGSKMBIUEJOB-FXQIFTODSA-N Pro-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H]1CCCN1 ALJGSKMBIUEJOB-FXQIFTODSA-N 0.000 description 1
- CQZNGNCAIXMAIQ-UBHSHLNASA-N Pro-Ala-Phe Chemical compound C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O CQZNGNCAIXMAIQ-UBHSHLNASA-N 0.000 description 1
- OYEUSRAZOGIDBY-JYJNAYRXSA-N Pro-Arg-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OYEUSRAZOGIDBY-JYJNAYRXSA-N 0.000 description 1
- FKKHDBFNOLCYQM-FXQIFTODSA-N Pro-Cys-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O FKKHDBFNOLCYQM-FXQIFTODSA-N 0.000 description 1
- HQVPQXMCQKXARZ-FXQIFTODSA-N Pro-Cys-Ser Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O HQVPQXMCQKXARZ-FXQIFTODSA-N 0.000 description 1
- FRKBNXCFJBPJOL-GUBZILKMSA-N Pro-Glu-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FRKBNXCFJBPJOL-GUBZILKMSA-N 0.000 description 1
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 1
- STASJMBVVHNWCG-IHRRRGAJSA-N Pro-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 STASJMBVVHNWCG-IHRRRGAJSA-N 0.000 description 1
- AUQGUYPHJSMAKI-CYDGBPFRSA-N Pro-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 AUQGUYPHJSMAKI-CYDGBPFRSA-N 0.000 description 1
- XYSXOCIWCPFOCG-IHRRRGAJSA-N Pro-Leu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XYSXOCIWCPFOCG-IHRRRGAJSA-N 0.000 description 1
- AWQGDZBKQTYNMN-IHRRRGAJSA-N Pro-Phe-Asp Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC(=O)O)C(=O)O AWQGDZBKQTYNMN-IHRRRGAJSA-N 0.000 description 1
- FYKUEXMZYFIZKA-DCAQKATOSA-N Pro-Pro-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O FYKUEXMZYFIZKA-DCAQKATOSA-N 0.000 description 1
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 1
- RCYUBVHMVUHEBM-RCWTZXSCSA-N Pro-Pro-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RCYUBVHMVUHEBM-RCWTZXSCSA-N 0.000 description 1
- KBUAPZAZPWNYSW-SRVKXCTJSA-N Pro-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KBUAPZAZPWNYSW-SRVKXCTJSA-N 0.000 description 1
- IURWWZYKYPEANQ-HJGDQZAQSA-N Pro-Thr-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O IURWWZYKYPEANQ-HJGDQZAQSA-N 0.000 description 1
- DCHQYSOGURGJST-FJXKBIBVSA-N Pro-Thr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O DCHQYSOGURGJST-FJXKBIBVSA-N 0.000 description 1
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 1
- BXHRXLMCYSZSIY-STECZYCISA-N Pro-Tyr-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(O)=O BXHRXLMCYSZSIY-STECZYCISA-N 0.000 description 1
- 108010079005 RDV peptide Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 102000037054 SLC-Transporter Human genes 0.000 description 1
- 108091006207 SLC-Transporter Proteins 0.000 description 1
- FIXILCYTSAUERA-FXQIFTODSA-N Ser-Ala-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIXILCYTSAUERA-FXQIFTODSA-N 0.000 description 1
- IDQFQFVEWMWRQQ-DLOVCJGASA-N Ser-Ala-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IDQFQFVEWMWRQQ-DLOVCJGASA-N 0.000 description 1
- HJEBZBMOTCQYDN-ACZMJKKPSA-N Ser-Glu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HJEBZBMOTCQYDN-ACZMJKKPSA-N 0.000 description 1
- YRBGKVIWMNEVCZ-WDSKDSINSA-N Ser-Glu-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O YRBGKVIWMNEVCZ-WDSKDSINSA-N 0.000 description 1
- RIAKPZVSNBBNRE-BJDJZHNGSA-N Ser-Ile-Leu Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O RIAKPZVSNBBNRE-BJDJZHNGSA-N 0.000 description 1
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 1
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 1
- XKFJENWJGHMDLI-QWRGUYRKSA-N Ser-Phe-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O XKFJENWJGHMDLI-QWRGUYRKSA-N 0.000 description 1
- XQAPEISNMXNKGE-FXQIFTODSA-N Ser-Pro-Cys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CS)C(=O)O XQAPEISNMXNKGE-FXQIFTODSA-N 0.000 description 1
- FLONGDPORFIVQW-XGEHTFHBSA-N Ser-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FLONGDPORFIVQW-XGEHTFHBSA-N 0.000 description 1
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 description 1
- LVHHEVGYAZGXDE-KDXUFGMBSA-N Thr-Ala-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(=O)O)N)O LVHHEVGYAZGXDE-KDXUFGMBSA-N 0.000 description 1
- CEXFELBFVHLYDZ-XGEHTFHBSA-N Thr-Arg-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CEXFELBFVHLYDZ-XGEHTFHBSA-N 0.000 description 1
- ODSAPYVQSLDRSR-LKXGYXEUSA-N Thr-Cys-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O ODSAPYVQSLDRSR-LKXGYXEUSA-N 0.000 description 1
- VYEHBMMAJFVTOI-JHEQGTHGSA-N Thr-Gly-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O VYEHBMMAJFVTOI-JHEQGTHGSA-N 0.000 description 1
- YZUWGFXVVZQJEI-PMVVWTBXSA-N Thr-Gly-His Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O YZUWGFXVVZQJEI-PMVVWTBXSA-N 0.000 description 1
- XOWKUMFHEZLKLT-CIQUZCHMSA-N Thr-Ile-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O XOWKUMFHEZLKLT-CIQUZCHMSA-N 0.000 description 1
- PRNGXSILMXSWQQ-OEAJRASXSA-N Thr-Leu-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PRNGXSILMXSWQQ-OEAJRASXSA-N 0.000 description 1
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 1
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 1
- FRQRWAMUESPWMT-HSHDSVGOSA-N Thr-Trp-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)O)N)O FRQRWAMUESPWMT-HSHDSVGOSA-N 0.000 description 1
- UABYBEBXFFNCIR-YDHLFZDLSA-N Tyr-Asp-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UABYBEBXFFNCIR-YDHLFZDLSA-N 0.000 description 1
- CNLKDWSAORJEMW-KWQFWETISA-N Tyr-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O CNLKDWSAORJEMW-KWQFWETISA-N 0.000 description 1
- PMDWYLVWHRTJIW-STQMWFEESA-N Tyr-Gly-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PMDWYLVWHRTJIW-STQMWFEESA-N 0.000 description 1
- AZGZDDNKFFUDEH-QWRGUYRKSA-N Tyr-Gly-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AZGZDDNKFFUDEH-QWRGUYRKSA-N 0.000 description 1
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 1
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 1
- ZLFHAAGHGQBQQN-GUBZILKMSA-N Val-Ala-Pro Natural products CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O ZLFHAAGHGQBQQN-GUBZILKMSA-N 0.000 description 1
- OVLIFGQSBSNGHY-KKHAAJSZSA-N Val-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N)O OVLIFGQSBSNGHY-KKHAAJSZSA-N 0.000 description 1
- UKEVLVBHRKWECS-LSJOCFKGSA-N Val-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)N UKEVLVBHRKWECS-LSJOCFKGSA-N 0.000 description 1
- QRVPEKJBBRYISE-XUXIUFHCSA-N Val-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N QRVPEKJBBRYISE-XUXIUFHCSA-N 0.000 description 1
- VIKZGAUAKQZDOF-NRPADANISA-N Val-Ser-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O VIKZGAUAKQZDOF-NRPADANISA-N 0.000 description 1
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 1
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 1
- UFCHCOKFAGOQSF-BQFCYCMXSA-N Val-Trp-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N UFCHCOKFAGOQSF-BQFCYCMXSA-N 0.000 description 1
- ZLMFVXMJFIWIRE-FHWLQOOXSA-N Val-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](C(C)C)N ZLMFVXMJFIWIRE-FHWLQOOXSA-N 0.000 description 1
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 108010029539 arginyl-prolyl-proline Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 108010054813 diprotin B Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 108010018006 histidylserine Proteins 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 1
- 108010051673 leucyl-glycyl-phenylalanine Proteins 0.000 description 1
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 230000003304 psychophysiological effect Effects 0.000 description 1
- 230000002294 pubertal effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 238000011824 transgenic rat model Methods 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Neurology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The application discloses a method for precisely separating rat KISS1 neurons, which belongs to the technical field of biomedicine, and comprises the steps of specifically expressing genes corresponding to proteins on cell membranes of the KISS1 neurons and sorting positive cells with specific gene coding proteins in arciform nucleus areas in hypothalamus by adopting flow cytometry, namely sorting out the selected KISS1 neurons; the application provides a method for finding out a specific gene corresponding to a specific expression protein on a cell membrane of a KISS1 neuron to determine a specific gene Slc18a 3; the extraction method provided by the application does not need to breed transgenic rats in the implementation process, has low experimental cost and is suitable for popularization; the KISS1 neuron cells obtained by the extraction method provided by the application are living cells, nucleic acid and protein in the cells can not be damaged, and the extracted KISS1 neuron cells can be used for subsequent cells and molecular experiments.
Description
Technical Field
The application relates to the technical field of biomedicine, in particular to a method for precisely separating rat KISS1 neurons;
background
Puberty is one of the most important stages in the human developmental process, activation of the puberty genital axis (hypothalamic-pituitary-gonadal axis, hypothalamic Pituitary gonadal axis, HPG), the dramatic increase in sex hormones, which causes great changes in tissue organ structure, physiology and psychology; pubertal dysplasia may be closely related to the occurrence of later growth, development, reproduction, endocrine, metabolism and psychophysiological diseases, and is one of the hot spots focused on reproductive endocrine research; gonadotropin releasing hormone (Gonadotropin-releasing hormone, gnRH) rhythmic secretion is a marker for initiation of pubertal development; at present, research is considered that the development and function of GnRH neurons are started and regulated by a plurality of regulating factors and intercellular signal transduction systems in the central nervous system; of these, kisspptin protein encoded by KISS1 metastasis suppressor (KISS 1) gene and corresponding receptor KISS1 receptor (also called GPR 54) are considered to be the most critical acting factors for regulating GnRH neuron secretion GnRH; the kit is characterized in that KISS1 neurons distributed at the hypothalamic arciform nucleus position synthesize kisspeptin proteins, and the proteins act on GnRH neurons through paracrine; gnRH neuron surface GPR54 receptor responds to kisspeptin, and further, Gαq/11 coupled K ion channels are activated to continuously depolarize GnRH neurons, so that the regulation and control effect on an HPG axis is exerted; therefore, the KISS1 neuron expressing and secreting the kisspeptin is one of research hotspots for exploring the hypothalamic neuroendocrine network triggering mechanism in adolescent maturity at present and is also one of important acting objects for researching and treating sexual dysplasia diseases.
Common animal models for studying pubertal development are Sprague Dawley strain rats in rodents (hereinafter SD rats); it is generally considered that the 25 th day (PND 25 for short herein), 35 th day (PND 35 for short herein) and 45 th day (PND 45 for short herein) after birth of the rat correspond to the juvenile, adolescent and sexual maturity periods of the human, respectively; the research on the cell and biochemical mechanism of HPG axis activation and silencing is carried out by researching hypothalamic tissues of SD rats at different growth and development time points and combining indexes such as lutein (luteinizing hormone, LH), follicle Stimulating Hormone (FSH) and the like in blood; to date, people generally dye important markers such as kisspeptin on the whole hypothalamus by Immunofluorescence (IF) or fluorescence in situ hybridization (Fluorescence in situ hybridization, FISH), and focus on detection of kisspeptin and other proteins in the arciform nucleus region rich in KISS1 neurons; however, this approach does not isolate KISS1 neurons alone; many studies involve high throughput gene sequencing or chip, often only the approximate location of the arcuately shaped nucleus, and even the entire hypothalamus, can be detected, which undoubtedly brings other types of neurons into the research system, greatly affecting the end result; in order to solve the problem, a green fluorescent protein (Green Fluorescent Protein, GFP) or beta-galactosidase transgenic rat is constructed, and a common method is to insert a GFP or beta-galactosidase between a promoter of a KISS1 gene and the KISS1 gene, so that the KISS1 neuron expresses GFP or beta-galactosidase while expressing the KISS1 gene, and finally forms a fusion protein of kisspeptin, and then GFP or beta-galactosidase positive cells are separated, thereby achieving the purpose of obtaining the KISS1 neuron; however, the problems of transgenic rats mainly include three aspects, namely unstable expression, and research data from different laboratories show that GFP or beta galactosidase can appear in the hypothalamic non-arciform nucleus region to cause false positives, and the expression abundance is very low when the expression should be carried out; 2. the kisspptin-GFP fusion protein is likely to cause abnormal structure of N-terminal or C-terminal protein of kisspptin, resulting in functional inactivation; 3. the cost is high, the transgenic rats need to be continuously bred in a laboratory with animal houses for seed conservation, and at present, the transgenic rats are only owned by a few laboratories worldwide and are not popularized; thus, there is a lack of a method by which the KISS1 neurons can be isolated accurately, and the platforms, instrumentation and techniques required for such a method are acceptable to most laboratories.
Disclosure of Invention
The present application aims to provide a method for precisely isolating rat KISS1 neurons, which solves the problems set forth in the background art;
in order to achieve the above purpose, the present application provides the following technical solutions: a method for precisely isolating rat KISS1 neurons, the method comprising the steps of:
a method for precisely isolating rat KISS1 neurons, the method comprising the steps of:
step one, finding out genes corresponding to the specific expression proteins on the cell membrane of the KISS1 neuron;
s11, embedding the whole brain of the SD rat with an OCT embedding medium and then fully cooling;
s12, slicing the hypothalamus of the SD rat treated by the step S11;
s13, placing the slice in a capture area of a special slide glass for constructing the space transcriptome library, fixing and permeabilizing the slice to release all RNA in cells and combine the RNA with a corresponding capture probe, and synthesizing cDNA by taking the captured RNA as a template to prepare a sequencing library; performing second-generation high-throughput short-reading long-sequencing on the prepared sequencing library;
s14, clustering the points of the captured area in a dimension reduction manner according to the significance differences of all the detectable gene expression in each point set, selecting a point set with significant high expression of the KISS1, further clustering in a dimension reduction manner according to the significance differences of all the detectable gene expression in the point set, and selecting a subset with significant high expression of the KISS 1; screening out a cell membrane expression specific marker of which the Slc18a3 is taken as a significant high expression subset of the KISS1, wherein the Slc18a3 gene is a nucleotide SEQUENCE shown as SEQUENCE LISTING ID NO. 1;
step two, sorting KISS1 neuron cells in the arciform nucleus region in hypothalamus by adopting a flow cytometry according to the Slc18a3 protein, wherein the Slc18a3 protein is an amino acid SEQUENCE shown in SEQUENCE LISTING ID NO.3, and the specific steps are as follows:
s21, taking an arciform nucleus region in hypothalamus, processing the arciform nucleus region into single-cell suspension, and re-suspending cells to about 5x106 cells/mL in ice-cold phosphate buffer saline solution containing 10% fetal calf serum and 1% sodium azide;
s22, adding the resuspended cell fluid obtained in the S21 into the Slc18a3 protein antibody, and incubating in the absence of light;
s23, centrifuging the cell sap obtained in the S22 after light-shielding incubation, re-suspending in an ice phosphate buffer salt solution, and repeating the operation for 3 times;
s24, adding anti-rabbit FITC secondary antibody into the cell fluid obtained in the S23, and incubating in a dark place on ice;
s25, after centrifuging the cell fluid obtained in the S24, re-suspending in an ice phosphate buffer salt solution, and repeating the operation for 3 times;
s26, adding 7-amino actinomycin D into the cell fluid obtained in the S25, and incubating at normal temperature;
s27, adopting a flow type sorter to carry out flow type sorting.
As a preferable technical scheme of the application, in the step S12, the section is tissue with the chimney spacing of 2.52-2.92mm and the double ear spacing of 6.08-6.48 mm.
As a preferred technical scheme of the application, the specific gene screening method in the step S14 specifically comprises the following steps: the genes of which the expressed proteins are on the cell membrane of the KISS1 neurons are selected from genes of which the subset with the remarkably high expression of the KISS1 has remarkably high expression relative to the other three subsets are analyzed and found by means of bioinformatics.
As a preferred technical scheme of the application, the S27 medium-flow sorting method of the second step specifically comprises the steps of firstly removing adhesive cells, then removing 7-amino actinomycin D positive dead cells, finally removing fragments, simultaneously obtaining FSC large and FSC small two groups of cells which are neurons and glial cells respectively, and then sorting the two groups of cells to obtain specific protein positive glial cells, specific protein negative glial cells, specific protein positive neuron cells and specific protein negative neuron cells, wherein the specific protein positive neuron cells are target cells;
as a preferable technical scheme of the application, the cooling temperature in the first step is-80 ℃.
As a preferred embodiment of the present application, in the step S12, SD rat hypothalamus is placed in a frozen microtome at-20℃and the slice thickness is 10. Mu.m.
As a preferable technical scheme of the application, in the step S14, the points of the capturing area are clustered into 14 point sets after dimension reduction according to the significance degree of the whole gene expression, the point set with the significant high expression of the KISS1 is selected, and the point sets are further clustered into 4 subsets after dimension reduction according to the significance degree of the whole gene expression.
Compared with the prior art, the application has the beneficial effects that:
the application provides a method for extracting the living cells of the KISS1 neurons by specifically expressing the genes corresponding to the proteins on the cell membranes of the KISS1 neurons, and realizes the accurate separation of the KISS1 neurons on wild SD rats. Compared with the prior art, the extraction method provided by the application does not need to breed transgenic rats in the implementation process, has low experimental cost and is suitable for popularization; in addition, the KISS1 neuron cells obtained by the KISS1 neuron extraction method provided by the application are living cells, nucleic acid and protein in the cells and the inside of the cells are not damaged, and the extracted KISS1 neuron cells can be used for subsequent cells and molecular experiments.
Drawings
FIG. 1 is a schematic representation of the distribution of the 1-14 point set over the spatial location of brain slices of 25 day SD rats;
FIG. 2 is a schematic representation of the distribution of the 1-14 point set over the spatial location of brain slices of 35 day SD rats;
FIG. 3 is a schematic representation of the distribution of the 1-14 point set over the spatial location of brain slices of 45 day SD rats;
FIG. 4 is a plot of violin at levels expressed by KISS1 neurons in different sets of points;
FIG. 5 is a diagram showing t-SNE grouping among 4 sub-set samples obtained by dimension reduction of a ninth point set in the application;
FIG. 6 is a graph showing the ratio of free single cells removed by the PND25 rat arcuate core flow assay of the present application;
FIG. 7 is a graph showing the ratio of viable cells positive for 7-amino actinomycin D selected in the arcuate nuclear flow sorting of PND25 rats according to the present application;
FIG. 8 is a graph showing FSC/SSC results in a PND25 rat arcuate core flow assay according to the present application;
FIG. 9 is a graph showing further sorting results of FSC large cell populations in PND25 rat arcuate core flow sorting according to the present application;
FIG. 10 is a graph showing the ratio of free single cells removed by PND35 rat arcuate core flow sorting in accordance with the present application;
FIG. 11 is a graph showing the ratio of viable cells positive for 7-amino actinomycin D selected in the arcuate nuclear flow sorting of PND35 rats according to the present application;
FIG. 12 is a graph showing FSC/SSC results in a PND35 rat arcuate core flow assay according to the present application;
FIG. 13 is a graph showing further sorting results of FSC large cell populations in PND35 rat arcuate core flow sorting according to the present application;
FIG. 14 is a graph showing the ratio of free single cells removed by the PND45 rat arcuate core flow assay of the present application;
FIG. 15 is a graph showing the ratio of viable cells positive for 7-amino actinomycin D selected in the arcuate nuclear flow sorting of PND45 rats according to the present application;
FIG. 16 is a graph showing FSC/SSC results in a PND45 rat arcuate core flow assay of the present application;
FIG. 17 is a graph showing the further sorting results of FSC large cell populations in PND45 rat arcuate nuclear flow sorting according to the present application.
Detailed Description
In order that those skilled in the art will better understand the present application, a technical solution in the embodiments of the present application will be clearly and completely described in the following description with reference to the accompanying drawings in which it is apparent that the described embodiments are only some embodiments of the present application, not all embodiments; all other embodiments, based on the embodiments of the application, which would be apparent to one of ordinary skill in the art without having made inventive work, are intended to be within the scope of the application;
it should be noted that, without conflict, the embodiments of the present application and features in the embodiments may be combined with each other, and the present application will be described in detail with reference to the embodiments.
Example 1
The application provides a method for precisely isolating rat KISS1 neurons, which is concretely as follows.
Finding out the specific expression protein on the cell membrane of the KISS1 neuron:
s1, taking 1 complete hypothalamus of SD rats of 25 days after birth (PND 25 for short), 35 days after birth (PND 35 for short) and 45 days after birth (PND 45 for short), placing the basal part of the whole brain at the bottom of a specimen holder, uniformly smearing with an OCT embedding medium (Thermo Fisher Scientific) until the whole brain is completely covered, and fully cooling at-80 degrees;
s2, placing the cooled hypothalamus in a-20-degree frozen microtome, cutting the hypothalamus vertically to the longitudinal split of the brain, cutting the coronal plane of the position of the anterior chimney with 2.52-2.92mm and the position of the double ears with 6.08-6.48mm, wherein the thickness of the slice is 10 mu m;
s3, placing the slices on a capturing area of a special glass slide for constructing a 10x Genomics space transcriptome library, taking three hypothalamic slices of rats with different ages, respectively placing the hypothalamic slices on different capturing areas of the same glass slide, wherein the size of each capturing area is 6.5x6.5mm, each capturing area comprises 5000 bar code marked points (barcoded Spots), the diameter of each point is 55 mu m, the center distance between adjacent points is 100 mu m, each point contains capturing probes, and all probes in each point have a unique barcode sequence; fixing and permeabilizing the section, releasing RNA in the cells, and binding to the corresponding capture probes; using the captured RNA as a template, synthesizing cDNA, and sequencing library preparation; and carrying out second-generation high-throughput short-reading long-sequencing on the prepared sequencing library. The number of high-quality spots of Space Ranger quantitative quality control of samples at different time points is distributed between 3894 and 4317, the average UMI number in each sPot is distributed between 26546 and 33158, the average base factor in each sPot is distributed between 4881 and 5312, and the average mitochondrial gene proportion in each sPot is distributed between 27.22 and 28.26 percent.
S4, clustering the point clusters of each capturing area in S3 into 14 point sets according to the significance difference of all the detectable gene expression in each point set, wherein the distribution schematic diagrams of different point sets on sample space slice positions are reflected in FIGS. 1-3, and each area in the diagrams is formed by a plurality of discontinuous point circles; the numbers marked in the figures are point set numbers corresponding to the positions, and fig. 1 is a schematic diagram of brain sections of 25-day SD rats; FIG. 2 is a schematic representation of brain sections of 35 day SD rats, and FIG. 3 is a schematic representation of brain sections of 45 day SD rats; as can be seen from fig. 1-3, the positions of the points in each set of points in the slice are substantially continuous. The result of the abundance of the expression of the KISS1 neurons in the 14-point set is shown in fig. 4, wherein the abundance of the expression of the KISS1 neurons in the ninth point set is the highest, and as can be seen from the combination of fig. 1-3, all points in the ninth point set are positioned in the arciform nucleus region in the hypothalamic section, which is the highest consistent with the content of the KISS1 neurons in the arciform nucleus region in the prior research result;
further dimension-reducing clustering the ninth point set into 4 subsets according to the significance differences of all detectable gene expression in each point set, and as a result, the numbers in the curve areas in fig. 5 correspond to the subset labels as shown by the areas marked by the four curve coils in fig. 5; the difference of the expression of the KISS1 genes in the 4 subsets is counted, and a subset with obviously high expression of the KISS1 is selected, wherein the concrete counting method is as follows: counting the differences in expression of KISS1 in each subset relative to the expression in the other three subsets; the specific calculation method is the ratio of the expression quantity of the KISS1 expressed in a certain subset to the average value of the expression quantities in the remaining three subsets; the P value represents the statistically significant value of the gene expression protein difference, represents the degree of dispersion of the value of the expression difference obtained from 3 samples, and is statistically significant when the P value is less than 0.05 according to the statistical knowledge; comparing the difference of the expression levels of the KISS1 genes of the 4 subsets, the expression of the KISS1 in the 1 # subset is obviously higher than that of the expression of the KISS1 in 1 # subsets of the other 3 subsets, and the P value is 3.58x10-24, which indicates that the KISS1 neurons are mainly concentrated in the 1 # subset on the 9 # point set; the KISS1 gene is the nucleotide SEQUENCE shown in SEQUENCE LISTING ID NO. 2;
genes in subset 1 were then screened for significantly higher expression than the other three subsets. The screening method is as follows, the expression difference of all genes in the subset 1 relative to the other three subsets is counted, and the specific calculation method is that the larger the ratio is, the larger the expression difference is, namely the more the genes can be used as specific genes of the subset. Finally, the Slc18a3 gene was selected. The Slc18a3 gene is the nucleotide SEQUENCE shown in SEQ LISTING ID NO. 1; the Slc18A3 protein is a member of subfamily A subfamily 3 of solute carrier 18, designated generally as solute carrier family 18 membrane A3, and is commonly designated as Slc18A3. The Slc18a3 protein is an amino acid SEQUENCE shown in SEQUENCE LISTING ID NO. 3; the Slc18a3 protein is a transmembrane protein responsible for the absorption and transport of amino acids, nucleotides, sugars, inorganic ions and drugs on the cell membrane. The expression difference of the Slc18a3 protein is 6, the P value is 5.10E-18, which indicates that the expression quantity of the Slc18a3 protein in subset 1 is 6 times of the average value of the expression quantity of other 3 subsets, so that the Slc18a3 is a specific gene positioned on the cell membrane of the KISS1 neuron; at P values less than 0.05, the fold difference in expression is statistically significant.
KISS1 neuronal cells highly expressing the Slc18a3 protein in the arciform nuclear region in the hypothalamus of PND25 SD rat were sorted using flow cytometry. The tissue at the hypothalamic arcuate nucleus site of 30 rats was treated with Neural Tissue Dissociation Kits (Meitian, 130-092-628) and gentle MACS TM Octo Dissociator with Heaters to a single cell suspension, and the single cell suspension was resuspended to about 5X10 cells in an ice phosphate buffered saline solution containing 10% fetal bovine serum, 1% sodium azide 6 cells/mL; then 30. Mu.L of Slc18a3 antibody (Abclonal, manufactured) was added and incubated for 30min on ice protected from light; centrifuging at 400g for 5min after incubation, then re-suspending in ice phosphate buffer salt solution, and repeating the centrifugation re-suspending operation for 3 times; then 15. Mu.L of anti-rabbit FITC secondary antibody (manufactured by Abcam) was added, and incubated on ice for 30min in the absence of light; centrifuging at 400g for 5min, then re-suspending in ice phosphate buffer salt solution, and repeating the centrifugation re-suspending operation for 3 times; adding 5 μl of 7-amino actinomycin D (manufactured by Biyun) and incubating at room temperature for 15min; flow separation by AriaIII flow sorter (manufactured by Becton, dickinson and Company) is carried out by first removing adherent cells by FSCA/H and gating to separate brain tissue into individual free cells, as shown in the inner region of the frame line in FIG. 6The proportion of isolated cells to the total number of cells was 70.88%; then removing 7-amino actinomycin D positive dead cells to obtain 7-amino actinomycin D positive living cells, and the result is shown in figure 7, wherein the 7-amino actinomycin D positive living cells account for 89.48% of the total number of free cells; then FSC/SSC (FSC is a general abbreviation of forward scale, which represents forward scattered light, the parameter is proportional to the size of cells; SSC is a abbreviation of side scale, which represents side scattered light, the parameter reflects the complexity of cells, such as how many particles are in the cell), debris is removed by gating, the cells are divided into two groups according to the FSC parameter, the group with large FSC parameter is called FSC large cell group, and the group with small FSC parameter is called FSC small cell group, so that two groups of cells, namely FSC large cell and FSC small cell, are obtained, and the result is shown in a box line area in FIG. 8, wherein the FSC large cell is neuron, accounts for 31.17% of the total number of viable cells positive for 7-amino actinomycin D, the FSC small cell is glial cell, and accounts for 31.74% of the total number of viable cells positive for 7-amino actinomycin D; the FSC large cell population was then sorted, as shown in FIG. 9 by the corresponding box line P5, where the total number of the FSC large cells was 27.42% by the number of the SLC8a3 positive neuronal cells, so the total number of the SLC8a3 positive neuronal cells was 5.4% by the total hypothalamic tooling and area.
Example 2
The specific expression proteins found on the membranes of KISS1 neurons in example 2 are the same as in example 1 and will not be described in detail in this example.
KiSS1 neuronal cells with the Slc18a3 protein in the arciform nuclear region in the hypothalamus of PND35 SD rat were sorted using flow cytometry. The tissue at the hypothalamic arcuate nucleus site of 30 rats was treated with Neural Tissue Dissociation Kits (Meitian, 130-092-628) and gentle MACS TM Octo Dissociator with Heaters to a single cell suspension, and the single cell suspension was resuspended to about 5X10 cells in an ice phosphate buffered saline solution containing 10% fetal bovine serum, 1% sodium azide 6 cells/mL; then 30. Mu.L of slc18a3 antibody (Abclonal, manufactured) was added and incubated for 30min on ice protected from light; centrifugation at 400g for 5min after incubation was completed, followed by incubation in ice phosphate bufferRe-suspending in the solution, and performing centrifugal re-suspending operation for 3 times; then 15. Mu.L of anti-rabbit FITC secondary antibody (manufactured by Abcam) was added, and incubated on ice for 30min in the absence of light; centrifuging at 400g for 5 minutes, then re-suspending in ice phosphate buffer salt solution, and performing centrifugal re-suspending operation for 3 times; adding 5 μl of 7-amino actinomycin D (manufactured by Biyun) and incubating at room temperature for 15min; the method comprises the steps of carrying out flow separation by an AriaIII flow separator (manufactured by Becton, dickinson and Company), wherein FSCA/H is firstly adopted, a gate is arranged to remove adhesion cells, and brain tissue is divided into individual free cells, and the result shows that the proportion of the free cells to the total number of cells is 63.25% in the inner area of a frame line in FIG. 10; then, dead cells positive for 7-amino actinomycin D were removed to obtain live cells positive for 7-amino actinomycin D, and the result is shown in FIG. 11, wherein the live cells positive for 7-amino actinomycin D account for 84.79% of the total number of free cells; then FSC/SSC (FSC is a general abbreviation of forward scale, which represents forward scattered light, the parameter is proportional to the size of cells; SSC is a abbreviation of side scale, which represents side scattered light, the parameter reflects the complexity of cells, such as how many particles are in the cell), debris is removed by gating, the cells are divided into two groups according to the FSC parameter, the group with large FSC parameter is called FSC large cell group, and the group with small FSC parameter is called FSC small cell group, so that two groups of cells, namely FSC large cell and FSC small cell, are obtained, and the result is shown in a box line area in FIG. 12, wherein the FSC large cell is neuron, accounts for 16.26% of the total number of viable cells positive for 7-amino actinomycin D, the FSC small cell is glial cell, and accounts for 47.85% of the total number of viable cells positive for 7-amino actinomycin D; the FSC large cell population was then sorted, as shown in the corresponding box line at P5 in FIG. 13, wherein the slc8a3 positive neuronal cells account for 35.35% of the total FSC large cells, so the proportion of slc8a3 positive neuronal cells to total hypothalamic tooling and area was 3.08%.
Example 3
The specific expression proteins found on the membranes of KISS1 neurons in example 3 are the same as in example 1 and will not be described in detail in this example.
PND45 SD sorting by flow cytometryKISS1 neuronal cells with the Slc18a3 protein in the arciform nucleus region in the hypothalamus of rats. Hypothalamic tissue on a slide was treated with Neural Tissue Dissociation Kits (Meitian, 130-092-628) and gentle MACS TM Octo Dissociator with Heaters tissues at the hypothalamic arciform nucleus site of the rat to a single cell suspension, and then the single cell suspension was resuspended to about 5X10 cells in an ice phosphate buffered saline solution containing 10% fetal bovine serum, 1% sodium azide 6 cells/mL; then 30. Mu.L of slc18a3 antibody (Abclonal, manufactured) was added and incubated for 30min on ice protected from light; centrifuging at 400g for 5min after incubation, then re-suspending in ice phosphate buffer salt solution, and performing centrifugal re-suspending operation for 3 times; then 15. Mu.L of anti-rabbit FITC secondary antibody (manufactured by Abcam) was added, and incubated on ice for 30min in the absence of light; centrifuging at 400g for 5 minutes, then re-suspending in ice phosphate buffer salt solution, and performing centrifugal re-suspending operation for 3 times; adding 5 μl of 7-amino actinomycin D (manufactured by Biyun) and incubating at room temperature for 15min; the method comprises the steps of carrying out flow separation by an AriaIII flow separator (manufactured by Becton, dickinson and ComPany), wherein FSCA/H is firstly adopted, a gate is arranged to remove adhesion cells, brain tissue is divided into individual free cells, and the result shows that the proportion of the free cells to the total number of cells is 62.15% as shown in the inner area of a frame line in FIG. 14; then removing 7-amino actinomycin D positive dead cells to obtain 7-amino actinomycin D positive living cells, and the result is shown in figure 15, wherein the 7-amino actinomycin D positive living cells account for 93.13% of the total number of free cells; then FSC/SSC (FSC is a general abbreviation of forward scale, which means forward scattered light, this parameter is proportional to the size of the cells; SSC is a abbreviation of side scale, which means side scattered light, this parameter reflects the complexity of the cells, such as how many particles are inside the cells), gating off debris, dividing the cells into two large and small groups according to FSC parameters, the large FSC parameter group called FSC large cell group, and the small FSC parameter group called FSC small cell group, obtaining FSC large and FSC small cell groups, the result is shown in the box line region of FIG. 16, wherein FSC large cells are neurons, accounting for 18.11% of the total number of 7-amino actinomycin D positive living cells, FSC small cells are glial cells, accounting for44.62% of the total number of 7-amino actinomycin D positive living cells; the FSC large cell population was then sorted, as shown in the corresponding box line of P5 in fig. 17, where the slc8a3 positive neuronal cells account for 47.94% of the total FSC large cells, so the proportion of slc8a3 positive neuronal cells to total hypothalamic tooling and area total cells was 5.02%.
The foregoing description is only a preferred embodiment of the present application, but the scope of the present application is not limited thereto, and any person skilled in the art, who is within the scope of the present application, should make equivalent substitutions or modifications according to the technical solution of the present application and the inventive concept thereof, and should be covered by the scope of the present application.
Sequence listing
<110> Shanghai Kunlun Biotech Co., ltd
<120> a method for precisely isolating rat KiSS1 neurons
<130> 2021
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2862
<212> DNA
<213> rat genus (Rattus norvegicus)
<400> 1
ggcagcgcgg ctcacctcgg gggctccgtg cccgctgtgc gccgaagtcc aggctgagga 60
ggaggtctag agcccccggc tctcccgtct cccaccaggc tgcggggaac tggctgccgc 120
acccctcctc caagtggggg tagaacggag tctcaccccc ataggtccca gaactaaggg 180
gaacataggg ccggttcctc ccactgctca gccatcccca ggggcttgtc taggactata 240
gctctccaaa tcccccttcc cctggcttcc atcctgggcg catctcagaa gcggacccct 300
gcccggacgc gccccgcccc cggcccccgc cccgacgacg tcctattagc atgagcgacg 360
ccagtggccg gggcaccact cgggggccga gactcaccgc gtcatagccc caagtggagg 420
gagaaagaaa aaaaaagagg cggcggtgga ggaagaggca agagcggacg cgcggggagg 480
gctggagaga cggcgggcgg cggcagcatg cccctgggcg ggtgcacacg gcctctctgc 540
accgcagggg ctgcttctgc tctctctggg caccacgcgt ccagtctccc gcctcagccc 600
ctcggcttgc cggcctttgc ggttgcgctc gaaacatcgt ccactggtcc ccgaagcatc 660
taagagcagc ggcgccgcgc gggacaatcc ttgctttttt ctgagctcgg ggatatgagc 720
cccacagcca cctgaagcgc agggggcgct acgcggctag gaccgcgccc ccgaagtacc 780
ttatcctagc ctctgcactg cgggacgccg acacccgact ccggtggagg catcttaggg 840
aaagcagccg gtaggggcat ggaacccacc gcgccaaccg gtcaggcccg ggcggcggcc 900
accaaactgt cggaagcggt gggagccgcg ctacaagagc cccagaggca gcggcgcctg 960
gtgctggtca tcgtgtgcgt tgcactgtta ctggacaaca tgttgtacat ggtcatcgtg 1020
cccattgttc ccgactatat cgcccacatg cgcgggggca gcgagggccc gaccctggtc 1080
tctgaggtgt gggaacccac tctgccgccg cccactctgg ctaatgccag tgcctacttg 1140
gccaacacgt cggcgtcccc gacggctgcc gggtcggctc ggtcaatcct gcgacctcgc 1200
taccccacag aaagcgaaga tgtgaagata ggtgtgctgt ttgcctccaa ggctatcctg 1260
cagcttctgg tgaacccctt aagcgggcct ttcattgatc gcatgagcta cgacgtgccg 1320
ctgcttatag gcctgggcgt catgttcgcc tccacagtca tgtttgcctt tgcagaagac 1380
tatgccacgc tcttcgctgc gcgcagtcta caaggcctgg gctcggcctt cgcggacacg 1440
tctggcattg ccatgatcgc cgacaagtat cccgaggagc ctgagcgcag tcgtgccctg 1500
ggcgtggcgc tagcctttat tagctttgga agcctagtgg cgccaccgtt tgggggcatc 1560
ctctacgagt tcgcgggcaa gcgtgtaccc tttctagtgc tcgccgctgt gtcccttttc 1620
gacgcgctcc tgctcctggc ggtggctaag cccttctcgg ctgcggctcg ggcgcgagcc 1680
aacctgccgg tgggcacacc tatccatcgc ctcatgctag acccttacat cgctgtggta 1740
gccggcgcgc tcaccacttg taacattccc cttgcgttcc tcgagcccac catagccacg 1800
tggatgaagc acacaatggc cgcatccgag tgggagatgg gcatggtttg gctgccggct 1860
ttcgtgccac acgtgttagg cgtctacctc accgtgcgcc tggcggcgcg ttatccacac 1920
ctgcactggc tgtacggcgc tctcgggcta gcggtaattg gagtgagctc ttgcgtcgta 1980
cctgcctgtc gctcattcgc gccgttagtg gtctcgctct gcggactctg cttcggcatc 2040
gcgttagtgg acacagcgct cctacccacg ctcgcctttc tggtggacgt gcgccacgta 2100
tccgtctatg gcagtgtcta tgccatagct gacatctcct attctgtggc ctacgcgctc 2160
gggcccatag tggcaggcca catcgttcac tctcttggct ttgagcagct cagcctgggc 2220
atgggcctgg ccaacctgct ctacgcacca gtccttcttc ttttgcgcaa tgtaggcctc 2280
cttacacgct cgcgttcgga gcgcgatgtg ttgcttgatg aaccgccgca gggtctgtac 2340
gacgcggtgc gcctgcgtga ggtgcagggc aaggatggcg gcgaaccttg tagcccacct 2400
ggcccttttg acgggtgcga ggacgactac aactattact cccgcagcta gcagacccgc 2460
ttctcctcca ggccacctac ccgccccatt taggtcaaga tggtcattct gcaagagcac 2520
tgtccaactt tggcctgggg cccacctcct ctaatgaata ccctagcccc tcgcccgtcc 2580
tgaattcctt tgctggaatc ccttctccat gacccctccc agtctaggcc cctccccaaa 2640
cacactcgta ttcattgggg aaatggagca gggaggcaga agaagctgtt gggctcttgg 2700
cagaggtgaa gaggtgtgcg ggtgatcgcc aatcacctac tgagagcccc caaatagagt 2760
catgcatctg tttgtccttc ctgcggatct ttccagtgcc aaacttggtc tctgcactcc 2820
ggtgcctccg gcctgaatta ataaaccata tctatctgag ga 2862
<210> 2
<211> 5885
<212> DNA
<213> rat genus (Rattus norvegicus)
<400> 2
agatactttc tctgcattgt ttggggtaca atgagtctcc agctgcgagg gaggggtgtc 60
aagaggctag agatgatggg agagccagtg agcttatgag aacagccttg gatggtttct 120
gggggcgagc aagtcgctgg ctccagactt gagagccagg aggcgggggc cagagggagg 180
gagtggagcc ctgaggaggg tccgggaggg cagaggtggg attatgctgg gatacgtcac 240
ccatccagac ttcataaaag gggctgtgat cgggcagcca gatagaggaa gcccaggagc 300
cagaggctcc cctcagtgtg ctccaactac ccaagtggct cttctccctc cggccctcaa 360
gccaggaccc agccaaggta ggcacactgc ccacaggatt tgggactgcc ctgacccagg 420
gaggatctag aggagcaggc ctctaaccca aggccagttg aagcatcaag ggagaaggag 480
gcaaggaaag cagggatcca ggaatgcagt gatgaagacg ttgtcttgtg tcttgtgtgt 540
cgctgggtgt tctcagagcc cacttctgcc gcgtaaggag tggatgttgt aaagagactc 600
tttgtgggaa ctacctgaag ggagcttggc aagccctttg ggttcatggg ctcaccacgg 660
cttgtctgag cctttccccc caatataaaa ctaactatat acatatatat gctttgagca 720
acttgctaag aactgggggg ggggggggat accgctggaa ggagccatct tatgtcaaaa 780
accttctgat cacgcctaga atttctgttg tttactagat ctaaaagccc ctagagtgaa 840
aggaaccacc atgattgttc atggcagacc agataaacct cttccggttt cttacatact 900
gaaaggggga gagggggcgg gcatgttcct ttttgttttc taacatttca gttctcatgc 960
actgagcgct ctctagaata ggcaactgag agttattggg gtctggggta catgtggcat 1020
gtgtgttact tgtgggatgt gtgtggtatg tatgtgaggt gtttgtgctt cgtatgttat 1080
gacatttgtt tatcatttat ttttttctgc gcatgtgtgt aagcgcagag cacccagggg 1140
agtcagagga caactttctg gaggtggttt tctccctccg ccatgtgggt ccaaggggtt 1200
aaactgagat cgtcaagcgc ggtagctagc aagcacattt atctgctgag ccatcatctc 1260
accatgtcgg gtcattgtat gtagtgtgtt catatgtggt acgtgtgtat acgtggggta 1320
agggtgtgtc gtgagcaggc acagttctcc cttggtacac ttgaaaaatg ctgtccatga 1380
tagtgcagag tactagaggg atgagaggca gaagtctgga tcaccaacct ccccacctcc 1440
cctccctctc ctcccctccc cttcctccct ctccacctcc cctccccttc ctccctctcc 1500
acctcccctc ccctacctcc ctcaccacct tctctgttta gagaaaacac gaggtaccac 1560
ttacggagca cgctgacaca ttcctgccct cctcaggccc cgttggggta taacctggca 1620
tggcttcctc tccctataaa gcgctaactt tgtatccagc acctctatac ccagccctgc 1680
ctgccatcct ggaccccctg gcgtcatcgg tcctgcagat cccctgaggt ggcttctgag 1740
agccctcttc atctggtgca tgctggggtg ccagcaccag cccggaccct cccgtcagac 1800
tccccagctg ccatcagctg ttagcatgtg tctggtgtca ttttggaatg atctatttat 1860
acaagctgcc tgtgagtcaa ctagacatga gatcagaggg tccctgcacc ctcagcacct 1920
tgagatcagg gggtccctgc accctcagca ccccagcacc tacacagtac tacttgtatt 1980
gtcagtactt tcagcagtga cttcctaacc ctggtccttg tgatccagac cgtctactga 2040
ttttggtttc cactgtattt ctattcaagc ctcagggcat ctacagaaag tgcctggctt 2100
ttggaatgtc acagagtcat agtctgctag tcttggcagc catctcattg agcagctggg 2160
ggccaggcta accaatggtg cctggagatg ggtgtggtcc gcttatgtct cgtgggatga 2220
ggccagagct ggagcactga aactcaggat tcatgtgtga gtctggagtc aggtggcagg 2280
ggtaggactg gggacaaagt ggcaagatgc acggtgccga gagatcacgc catcatggct 2340
cacaaggata tctgtcctca ctcctgtcct tgaacagaag ccctgggttc cgcctgttgt 2400
gcctccagcc tcccagggca cttaatgcca tttgttggac agtttcaaag tgcttggtga 2460
cattttcaaa gggaaattgg acttgggagc tggagacgtg gggtggagtg gggagcagga 2520
gaggagaaag gtggagtggc cagatgaggg tcaggccaca cagctcctac ctcagcagtc 2580
aaactgatga ggccaattta gttcacaacc tcccagagcc cacgagaaca gaagtgactg 2640
acgggccaga ggagagaaag gctttccctg ccctgaatta taggcaataa gacagtttga 2700
tgatggtctc ccaggctgcg gagggctttg agaatgtgca agatgattgc ctctttcttc 2760
ctttttccct ggaagagaga agaaactggg tttctattat atcatgggga cagagctaga 2820
ttgaggaaga ttgggtgctg cgtaggagag cagagcacag gacccagcac ggggcttggt 2880
tccaggctcc caagagaata gttgaacctc agagcacact cctgcctgac cttaccaacc 2940
tccccctccc tgactactcc tgtgcatgac atttattctt cttcagcatc cctgccctgc 3000
aaaccttcca cccagagccc taccacggtc caaccaaggc ttctcagccc ttcccaccaa 3060
atcagaccct tcccattttc cctgccttct tccgtccctc agtcctgttt ccggtggcct 3120
tgtttggggc ttatccttct gatcatctct ggtcaccggg ctttctcctc tcccccaggc 3180
gctctctttg acctaggtag gctctggtga atactaactc tggcctggtc ttcattgcct 3240
ctcttcgtct cagcctctgg acaccctgtg gatctgcctc ttccagaatg atctcgctgg 3300
cttcttggca gctgctgctt ctcctctgtg tggcctcttt tggggagcca ctggcaaaaa 3360
tggcacctgt ggtgaaccct gaacccacag gtacacacca tcccggaaaa gggggcaaga 3420
gagtcagtgc acgtgagact cgctttattt gggctggaga gatggctcag tggttaagag 3480
cactggctgc tcttccagag gtcctgagtt caattcccag caaccacatg gtggctcaca 3540
accacctgta atgagattca atgccctttt ctggtgtgtc tgaagacaga gactcgctgt 3600
atttttcaga ctgtagccaa ggtaccgaca cgagttcagt ttctgcactt gagaaatact 3660
cagggctggc ccaggccctt ctgctgtgag caccgggagg ctcagttaga gtcaggggcc 3720
tgtcaaccct aactcctttg tgattttttt ctcctgccgt gctctgctct accccaagca 3780
cttgtcttta tggatgctgg aaaggagctt catgtgtaag ttacttttat ctgtgacctc 3840
agatcccgaa aggggacttg aaaacaaaac tcaaaaaatg tcaacacagc cgggcatggt 3900
ggcacaggcc tttaactcca gcactcagaa ggtagaagca ggtagatctc ttgagttcga 3960
cgtcagtcta gtccaggaca tccagggctc cgttacacag agaaattgtc tcaaacaaac 4020
aaacaaacaa acaaacaaac ccaatacagc aacaacctca tcatccacac agaccttaat 4080
gcccgtcaag ctacctcacg gattcactgg gggctttgat gaactggaga aactaaagcc 4140
caaagaggca aagtgctccc cagaggtgct cagtactgac aaatcccaac aggtgccagg 4200
gtacttccaa gagcatcgtg gcttctaagt cagggtgtgg gtttgaactt tccttagctg 4260
ttctgtttct gtacatatta gagcttgctt tagcctttct gcacctcaga acttaggcat 4320
agaatgcagg atacatcctg caaatttgac accatcatac ataagcaaag caacgggaac 4380
aggggcccaa acactctcca atagggtcac catccccaga taagaataac cccatcactg 4440
tgcagaaaca ctggctactg gccctttccg gctgcacagg ttatcctgat ctgaggttcg 4500
tgtgtagaac taagatcttt tctcccacac cagctatcca gagaaggtag gaggggcctc 4560
ccagactatt attattaatc ttggaccaca gccacactca tctccagagt gtgccagggt 4620
atggaggagc caacacccac tcacaccacc gttccttttt actaatctct gtccataatt 4680
gactagacgc attgtgtact cagagctact tgccctgttt tactggaaaa agagaaagag 4740
agagagagac agaatttaat gagccttgtc tatgaagtgt tttcagagtg agccttctta 4800
gcctccaaca agaagggaag gccttgcacc tcgcctggga gagctgtacc tgctaaggca 4860
atctagatag tgtctggcgt cacattgcgt cttgatactg tgtattaggg attgcagttg 4920
tcctcagaga ccagagtcag gtcacaggtg catgggggca caacagcctt ggctccactt 4980
tttttttatt tctgttactc caagtttttc attagctatt gcttaatgag cacgtattga 5040
ggccatacta tgtgcagggg tactgtttca agcattctta gagatggaga aatgaatccc 5100
ctccgtcccc ccctcccccg gaggctgctg gaccgttcca actcccaaca cagacactca 5160
actgaaggat caggcagaga gcccagaaga gggctagagc gagttccccc tctataccct 5220
cctttttttc tcttgcatgt tgtttgcgtc tcagaggagg tagttttata aacgtattta 5280
gtagaattct ggcgagcact tgaaagtaaa gctatggaag gagggaggag caaacagcca 5340
agccacccgg actaagcagg atcctggctc cacacagagg tcagagcagt atttctgagg 5400
ttgaggaccc agggccagca tcggaagggg agggaagtct gagctggtgt ccaaagcaag 5460
ccttgctgtc ccagcctcac tcctctgtac tctgtcctag gccaacagtc cggaccccag 5520
gaactcgtta atgcctggca aaagggcccg cggtatgcag agagcaagcc tggggctgca 5580
ggactgcgcg ctcgccgaac atcgccatgc ccgccggtgg agaaccccac ggggcaccag 5640
cggcccccgt gtgccacccg cagtcgcctg atccctgcgc cccgcggatc ggtgctggtg 5700
cagcgcgaga aggacatgtc agcctacaac tggaactcct ttggcctgcg ctacggcagg 5760
aggcaggtgg cgcgggcggc acggggctga gtgcagggtt gcaggtggat tgcagcccac 5820
cccatggcag aggccaaggc agggagcttc tagacttgtg caataaaagc aatgctgtcg 5880
cctta 5885
<210> 3
<211> 530
<212> PRT
<213> rat genus (Rattus norvegicus)
<400> 3
Met Glu Pro Thr Ala Pro Thr Gly Gln Ala Arg Ala Ala Ala Thr Lys
1 5 10 15
Leu Ser Glu Ala Val Gly Ala Ala Leu Gln Glu Pro Gln Arg Gln Arg
20 25 30
Arg Leu Val Leu Val Ile Val Cys Val Ala Leu Leu Leu Asp Asn Met
35 40 45
Leu Tyr Met Val Ile Val Pro Ile Val Pro Asp Tyr Ile Ala His Met
50 55 60
Arg Gly Gly Ser Glu Gly Pro Thr Leu Val Ser Glu Val Trp Glu Pro
65 70 75 80
Thr Leu Pro Pro Pro Thr Leu Ala Asn Ala Ser Ala Tyr Leu Ala Asn
85 90 95
Thr Ser Ala Ser Pro Thr Ala Ala Gly Ser Ala Arg Ser Ile Leu Arg
100 105 110
Pro Arg Tyr Pro Thr Glu Ser Glu Asp Val Lys Ile Gly Val Leu Phe
115 120 125
Ala Ser Lys Ala Ile Leu Gln Leu Leu Val Asn Pro Leu Ser Gly Pro
130 135 140
Phe Ile Asp Arg Met Ser Tyr Asp Val Pro Leu Leu Ile Gly Leu Gly
145 150 155 160
Val Met Phe Ala Ser Thr Val Met Phe Ala Phe Ala Glu Asp Tyr Ala
165 170 175
Thr Leu Phe Ala Ala Arg Ser Leu Gln Gly Leu Gly Ser Ala Phe Ala
180 185 190
Asp Thr Ser Gly Ile Ala Met Ile Ala Asp Lys Tyr Pro Glu Glu Pro
195 200 205
Glu Arg Ser Arg Ala Leu Gly Val Ala Leu Ala Phe Ile Ser Phe Gly
210 215 220
Ser Leu Val Ala Pro Pro Phe Gly Gly Ile Leu Tyr Glu Phe Ala Gly
225 230 235 240
Lys Arg Val Pro Phe Leu Val Leu Ala Ala Val Ser Leu Phe Asp Ala
245 250 255
Leu Leu Leu Leu Ala Val Ala Lys Pro Phe Ser Ala Ala Ala Arg Ala
260 265 270
Arg Ala Asn Leu Pro Val Gly Thr Pro Ile His Arg Leu Met Leu Asp
275 280 285
Pro Tyr Ile Ala Val Val Ala Gly Ala Leu Thr Thr Cys Asn Ile Pro
290 295 300
Leu Ala Phe Leu Glu Pro Thr Ile Ala Thr Trp Met Lys His Thr Met
305 310 315 320
Ala Ala Ser Glu Trp Glu Met Gly Met Val Trp Leu Pro Ala Phe Val
325 330 335
Pro His Val Leu Gly Val Tyr Leu Thr Val Arg Leu Ala Ala Arg Tyr
340 345 350
Pro His Leu Gln Trp Leu Tyr Gly Ala Leu Gly Leu Ala Val Ile Gly
355 360 365
Val Ser Ser Cys Val Val Pro Ala Cys Arg Ser Phe Ala Pro Leu Val
370 375 380
Val Ser Leu Cys Gly Leu Cys Phe Gly Ile Ala Leu Val Asp Thr Ala
385 390 395 400
Leu Leu Pro Thr Leu Ala Phe Leu Val Asp Val Arg His Val Ser Val
405 410 415
Tyr Gly Ser Val Tyr Ala Ile Ala Asp Ile Ser Tyr Ser Val Ala Tyr
420 425 430
Ala Leu Gly Pro Ile Val Ala Gly His Ile Val His Ser Leu Gly Phe
435 440 445
Glu Gln Leu Ser Leu Gly Met Gly Leu Ala Asn Leu Leu Tyr Ala Pro
450 455 460
Val Leu Leu Leu Leu Arg Asn Val Gly Leu Leu Thr Arg Ser Arg Ser
465 470 475 480
Glu Arg Asp Val Leu Leu Asp Glu Pro Pro Gln Gly Leu Tyr Asp Ala
485 490 495
Val Arg Leu Arg Glu Val Gln Gly Lys Asp Gly Gly Glu Pro Cys Ser
500 505 510
Pro Pro Gly Pro Phe Asp Gly Cys Glu Asp Asp Tyr Asn Tyr Tyr Ser
515 520 525
Arg Ser
530
<210> 4
<211> 130
<212> PRT
<213> rat genus (Rattus norvegicus)
<400> 4
Met Ile Ser Leu Ala Ser Trp Gln Leu Leu Leu Leu Leu Cys Val Ala
1 5 10 15
Ser Phe Gly Glu Pro Leu Ala Lys Met Ala Pro Val Val Asn Pro Glu
20 25 30
Pro Thr Gly Gln Gln Ser Gly Pro Gln Glu Leu Val Asn Ala Trp Gln
35 40 45
Lys Gly Pro Arg Tyr Ala Glu Ser Lys Pro Gly Ala Ala Gly Leu Arg
50 55 60
Ala Arg Arg Thr Ser Pro Cys Pro Pro Val Glu Asn Pro Thr Gly His
65 70 75 80
Gln Arg Pro Pro Cys Ala Thr Arg Ser Arg Leu Ile Pro Ala Pro Arg
85 90 95
Gly Ser Val Leu Val Gln Arg Glu Lys Asp Met Ser Ala Tyr Asn Trp
100 105 110
Asn Ser Phe Gly Leu Arg Tyr Gly Arg Arg Gln Val Ala Arg Ala Ala
115 120 125
Arg Gly
130
Claims (7)
1. A method for precisely isolating rat KISS1 neurons, the method comprising the steps of: step one, determining the specificity expression protein on the cell membrane of the KISS1 neuron; s11, embedding the whole brain of the SD rat with an OCT embedding medium and then fully cooling; s12, slicing the hypothalamus of the SD rat treated by the step S11; s13, placing the slice in a capture area of a special slide glass for constructing the space transcriptome library, fixing and permeabilizing the slice to release all RNA in cells and combine the RNA with a corresponding capture probe, and synthesizing cDNA by taking the captured RNA as a template to prepare a sequencing library; performing second-generation high-throughput short-reading long-sequencing on the prepared sequencing library; s14, clustering the points of the captured area in a dimension reduction manner according to the significance differences of all the detectable gene expression in each point set, selecting a point set with significant high expression of the KISS1, further clustering in a dimension reduction manner according to the significance differences of all the detectable gene expression in the point set, and selecting a subset with significant high expression of the KISS 1; screening out a cell membrane expression specific marker of which the Slc18a3 is taken as a significant high expression subset of the KISS1, wherein the Slc18a3 gene is a nucleotide SEQUENCE shown as SEQUENCE LISTING ID NO. 1; step two, sorting KISS1 neuron cells in the arciform nucleus region in hypothalamus by adopting a flow cytometry according to the Slc18a3 protein, wherein the Slc18a3 protein is an amino acid SEQUENCE shown in SEQUENCE LISTING ID NO.3, and the specific steps are as follows: s21, taking an arciform nucleus region in hypothalamus, processing the arciform nucleus region into single-cell suspension, and re-suspending cells to 5x106 cells/mL in ice-cold phosphate buffer saline solution containing 10% fetal calf serum and 1% sodium azide; s22, adding the resuspended cell fluid obtained in the S21 into the Slc18a3 protein antibody, and incubating in the absence of light; s23, centrifuging the cell sap obtained in the S22 after light-shielding incubation, re-suspending in an ice phosphate buffer salt solution, and repeating the operation for 3 times; s24, adding anti-rabbit FITC secondary antibody into the cell fluid obtained in the S23, and incubating in a dark place on ice; s25, after centrifuging the cell fluid obtained in the S24, re-suspending in an ice phosphate buffer salt solution, and repeating the operation for 3 times; s26, adding 7-amino actinomycin D into the cell fluid obtained in the S25, and incubating at normal temperature; s27, adopting a flow type sorter to carry out flow type sorting.
2. The method for precisely isolating rat KISS1 neurons according to claim 1, wherein the step S12 is performed with tissue having a pre-chimney spacing of 2.52-2.92mm and a binaural spacing of 6.08-6.48 mm.
3. The method for precisely isolating rat KISS1 neurons according to claim 1, wherein the specific gene screening method in step S14 is as follows: the genes of which the expressed proteins are on the cell membrane of the KISS1 neurons are selected from genes of which the subset with the remarkably high expression of the KISS1 has remarkably high expression relative to the other three subsets are analyzed and found by means of bioinformatics.
4. The method for precisely isolating rat KISS1 neurons according to claim 1, wherein the step S27 of the second method is specifically to remove adherent cells first, then remove dead cells positive for 7-amino actinomycin D, finally remove fragments, and obtain two groups of cells, namely neurons and glial cells, simultaneously, FSC large and FSC small, and then sort the two groups of cells to obtain specific protein positive glial cells, specific protein negative glial cells, specific protein positive neuronal cells and specific protein negative neuronal cells, wherein the specific protein positive neuronal cells are target cells.
5. A method for precisely isolating rat KISS1 neurons according to claim 1, characterized in that the cooling temperature in step one is-80 ℃.
6. A method for precisely isolating rat KISS1 neurons according to claim 1, wherein the SD rat hypothalamus is placed in a frozen microtome at-20 ℃ in step S12, with a slice thickness of 10 μm.
7. The method for precisely isolating rat KISS1 neurons according to claim 1, wherein in step S14, the points of the capturing region are clustered into 14 point sets according to the significance level of the whole gene expression, the point set with significantly high expression of KISS1 is selected, and the point set is further clustered into 4 subsets according to the significance level of the whole gene expression.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111136595.XA CN114045263B (en) | 2021-09-27 | 2021-09-27 | Method for precisely separating rat KISS1 neurons |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111136595.XA CN114045263B (en) | 2021-09-27 | 2021-09-27 | Method for precisely separating rat KISS1 neurons |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114045263A CN114045263A (en) | 2022-02-15 |
CN114045263B true CN114045263B (en) | 2023-09-26 |
Family
ID=80204870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111136595.XA Active CN114045263B (en) | 2021-09-27 | 2021-09-27 | Method for precisely separating rat KISS1 neurons |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114045263B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017108650A (en) * | 2015-12-15 | 2017-06-22 | 国立大学法人名古屋大学 | Immortalized neuronal cell line derived from hypothalamic reproductive center in livestock |
WO2020247936A2 (en) * | 2019-06-07 | 2020-12-10 | The General Hospital Corporation | Kisspeptins to predict and treat delayed puberty |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150141274A1 (en) * | 2012-05-09 | 2015-05-21 | The Rockefeller University | Methods and Compositions for Activity Dependent Transcriptome Profiling |
-
2021
- 2021-09-27 CN CN202111136595.XA patent/CN114045263B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017108650A (en) * | 2015-12-15 | 2017-06-22 | 国立大学法人名古屋大学 | Immortalized neuronal cell line derived from hypothalamic reproductive center in livestock |
WO2020247936A2 (en) * | 2019-06-07 | 2020-12-10 | The General Hospital Corporation | Kisspeptins to predict and treat delayed puberty |
Non-Patent Citations (4)
Title |
---|
Transcriptome‑scale spatial gene expression in rat arcuate nucleus during puberty;Zhou Shasha等;《Cell & Bioscience》;第12卷(第8期);全文 * |
下丘脑kisspeptin/神经激肽B/强啡肽神经元研究进展;杨亚茹;陈;卢苏;;新乡医学院学报(第06期);全文 * |
神经激肽B在大鼠下丘脑-垂体-卵巢轴上的表达;宋爽;崔培;王尧尧;蒋书东;章孝荣;方富贵;李福宝;;西北农林科技大学学报(自然科学版);第43卷(第06期);全文 * |
青春期代谢调控的新中枢神经通路;袁静怡;孙莹;;中国学校卫生(第06期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN114045263A (en) | 2022-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
De Canio et al. | Differential protein profile in sexed bovine semen: shotgun proteomics investigation | |
Saxena et al. | Trehalose-enhanced isolation of neuronal sub-types from adult mouse brain | |
Schenk et al. | Combined transcriptome and proteome profiling reveals specific molecular brain signatures for sex, maturation and circalunar clock phase | |
Grudniewska et al. | Transcriptional signatures of somatic neoblasts and germline cells in Macrostomum lignano | |
Hayward et al. | Differential gene expression at coral settlement and metamorphosis-a subtractive hybridization study | |
Ho et al. | A guide to single-cell transcriptomics in adult rodent brain: the medium spiny neuron transcriptome revisited | |
Yadav et al. | An immunological approach of sperm sexing and different methods for identification of X-and Y-chromosome bearing sperm | |
Cabrera et al. | Automated, high-throughput assays for evaluation of human pancreatic islet function | |
Sunanaga et al. | Postembryonic epigenesis of Vasa‐positive germ cells from aggregated hemoblasts in the colonial ascidian, Botryllus primigenus | |
Schwarz | Using fluorescence activated cell sorting to examine cell-type-specific gene expression in rat brain tissue | |
Samson et al. | found in neurons, a third member of the Drosophila elav gene family, encodes a neuronal protein and interacts with elav | |
Denver et al. | Comparative endocrinology in the 21st century | |
Mattera et al. | Isolation of oligodendroglial cells from young and adult whole rat brains using an in situ generated Percoll density gradient | |
Romero et al. | RNA-seq coupled to proteomic analysis reveals high sperm proteome variation between two closely related marine mussel species | |
Sunanaga et al. | Involvement of vasa homolog in germline recruitment from coelomic stem cells in budding tunicates | |
Chen et al. | Integrated analysis of quantitative proteome and transcriptional profiles reveals the dynamic function of maternally expressed proteins after parthenogenetic activation of buffalo oocyte | |
CN114045263B (en) | Method for precisely separating rat KISS1 neurons | |
Noda et al. | Sperm membrane proteins DCST1 and DCST2 are required for the sperm-egg fusion process in mice and fish | |
Berl et al. | Enrichment and isolation of neurons from adult mouse brain for ex vivo analysis | |
Mayer et al. | [3] Going in vivo with laser microdissection | |
Davies et al. | Where has all the message gone? | |
Meng et al. | Differentially-expressed opsin genes identified in Sinocyclocheilus cavefish endemic to China | |
EP1333099B1 (en) | Method of searching for gene encoding nuclear transport protein | |
CN106868117A (en) | Rare aquatile water sample environment DNA Optimal culture water sample pre-detection method | |
CN117202914A (en) | Method for quality control and enrichment of human dopaminergic nerve precursor cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |